The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 1 471-477
Copyright © 2003 by The Endocrine Society
Fetal Lung Maturation in Estrogen-Deprived Baboons
Gerald J. Pepe,
Philip L. Ballard and
Eugene D. Albrecht
Department of Physiological Sciences (G.J.P.), Eastern Virginia Medical School, Norfolk, Virginia 23501-1980; Department of Pediatrics (P.L.B.), University of Pennsylvania, Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania 19104; and Departments of Obstetrics/Gynecology/Reproductive Sciences and Physiology (E.D.A.), Center for Studies in Reproduction, University of Maryland School of Medicine, Baltimore, Maryland 21201-1509
Address all correspondence and requests for reprints to: Gerald J. Pepe, Ph.D., Department of Physiological Sciences, Eastern Virginia Medical School, P.O. Box 1980, Norfolk, Virginia 23501-1980. E-mail: pepegj{at}evms.edu.
 |
Abstract
|
|---|
We have previously shown that estrogen plays a central integrative role in regulating key aspects of fetal-placental development and that inhibition of estrogen production during the second half of baboon pregnancy suppressed fetal adrenal function. Because maturation of the fetal lung is dependent on cortisol of fetal adrenal origin, the current study determined whether lung development and expression of surfactant proteins (SPs) A and B were altered at term in estrogen-deprived baboons. Fetal lungs were obtained on d 100, 165, and 175 of gestation (term = d 184) from untreated baboons and on d 165 from animals treated daily during the second half of pregnancy either with the aromatase inhibitor CGS 20267 alone or with CGS 20267 and estradiol benzoate. Umbilical venous estradiol levels were suppressed by more than 95% by CGS 20267 and elevated by CGS 20267 and estrogen. Although umbilical serum cortisol levels were also suppressed by 35% by CGS 20267, cortisol levels in the fetal lung of estrogen-suppressed baboons were similar to values in untreated animals. Immunocytochemistry demonstrated that CGS 20267 treatment did not alter fetal lung expression of the 11ß-hydroxysteroid dehydrogenase enzyme-1 enzyme catalyzing reduction of cortisone to cortisol. However, immunocytochemical expression of the 11ß-hydroxysteroid dehydrogenase enzyme-2 catalyzing oxidation of cortisol to cortisone appeared lower in lungs of estrogen-deprived fetuses and restored to normal by CGS 20267 and estrogen. SP-A levels in fetal lungs of untreated baboons were increased 16- to 20-fold between d 100 and d 165175 of gestation in untreated baboons and baboons treated with CGS 20267 or CGS 20267 and estrogen. Similarly, SP-B levels in fetal lungs of untreated baboons were increased 10-fold between d 100 and d 165175 of gestation in untreated baboons and baboons treated with CGS 20267 or CGS 20267 and estrogen. Moreover, in estrogen-suppressed baboons, as in untreated animals, the fetal lung continued to grow and exhibited normal alveolarization on histology. We conclude that development of the primate fetal lung can occur in utero in baboons in which fetal serum cortisol levels have been suppressed by the relative absence of estrogen perhaps because of the ability of the lung to coordinate local production of cortisol.
 |
Introduction
|
|---|
OUR LABORATORIES HAVE shown that estrogen regulates the expression and subcellular localization of the 11ß-hydroxysteroid dehydrogenase enzymes (11ß-HSD)-1 and -2 within the syncytiotrophoblast (1), which causes increased transplacental oxidation of cortisol to cortisone during the second half of baboon gestation (2, 3). Consequently, this resulted in decreased maternal secretion of cortisol into the fetus, which resulted in enhanced fetal pituitary ACTH secretion (4) and maturation of de novo cortisol production by the baboon fetal adrenal gland (5, 6). Recently we showed that inhibition of estrogen production by administration of an aromatase inhibitor during the second half of baboon pregnancy suppressed 11ß-HSD-1 and -2 expression and compartmentalization within the syncytiotrophoblast, which we proposed would result in continued secretion of maternal cortisol into the fetus and thus inhibition of fetal adrenal maturation (7). Indeed, the activity and mRNA levels of the 3ß-hydroxysteroid dehydrogenase-isomerase enzyme catalyzing cortisol synthesis in the transitional zone of the fetal adrenal were significantly decreased at term in baboons in which the estrogen-dependent induction of placental cortisol oxidation was prevented by inhibition of the action (8) or the synthesis of estrogen (Albrecht, E. D. and G. J. Pepe, unpublished observations). It is well established that fetal adrenal cortisol is essential to activity and coordinated production of surfactant in and thus maturation of the fetal lung (9, 10, 11, 12, 13). Development of the baboon fetal lung has been extensively studied by Coalson et al. (14), who showed that cell-specific expression of the surfactant proteins A, B, and C increased markedly after d 120140 of gestation, the same interval during which estrogen-dependent maturation of the placental-fetal pituitary-adrenocortical axis occurs (6). As in the human, the baboon genome contains two surfactant protein (SP)-A genes (15), which encode SP-A proteins that are essentially identical and are developmentally regulated in part by cAMP and glucocorticoid (16).
Collectively, on the basis of these observations, it is possible that fetal lung development would also be compromised in primates in which fetal pituitary adrenocortical maturation was suppressed by estrogen deprivation. The current study was designed, therefore, to determine whether development and expression of surfactant proteins by the fetal lung are altered in baboons in which fetal adrenal maturation was prevented by suppressing estrogen.
 |
Materials and Methods
|
|---|
Animals
Fetal lungs were obtained on d 100 (n = 9), 160168 (n = 8), and 170175 (n = 8) of gestation (term = d 184) from untreated baboons and on d 160165 of gestation from baboons treated daily beginning on d 60 (n = 6) or 100 (n = 6) with the aromatase inhibitor CGS 20267 (Letrozol, 4,4''-[1,2,4,-triazol-1yl-methylene]bis-benzonitrite, Novartis Pharma AG, Basel, Switzerland) administered to the mother sc (12 mg/d per milliliter sesame oil). Samples were also collected on d 160165 from baboons treated with CGS 20267 (2 mg/d) and estradiol-benzoate beginning on d 60 (n = 4) or 100 (n = 3) of gestation at doses (1.02.0 mg/d per milliliter sesame oil) designed to replicate the normal pattern of serum estradiol as described previously (17). On d 100 or 165/175 of gestation, baboons were anesthetized with isoflurane-nitrous oxide, maternal saphenous and umbilical venous samples (36 ml) collected, the fetus delivered and euthanized with an overdose of sodium pentobarbital. The entire fetal lung was removed, weighed, and sections from each lobe stored in liquid nitrogen or fixed in 10% phosphate-buffered formalin. Animals were cared for and used strictly in accordance with USDA regulations and the NIH Guide for the Care and Use of Laboratory Animals (PHS publication no. 86-23, 1985). The experimental protocol was approved by the Institutional Animal Care and Use Committees of the Eastern Virginia Medical School and the University of Maryland School of Medicine.
SP-A and SP-B protein in fetal lung
The content of SP-A and SP-B in lung tissue was determined essentially as described by Ballard et al. (13). Briefly, aliquots of lung sonicate were serially diluted in PBS (pH 7.4, Sigma, St. Louis, MO) and applied to nitrocellulose membrane in a multiwell dot-blot apparatus under negative pressure (13). Each assay contained an equal number of samples from each treatment group to minimize interassay variability. Typically, six dilutions of each sample were applied along with 2-fold serial dilutions of pooled lung samples from animals of d 170175 gestation, which served as an internal standard. Membranes were blocked with a 5% milk protein solution, washed, and then exposed to rabbit polyclonal antibodies to human SP-A or human SP-B diluted 1:10,000 or 1:5,000, respectively (18, 19). Secondary antibody conjugated with horseradish peroxidase was used along with enhanced chemiluminescent reagents and the blots exposed to x-ray film for varying times to provide signals for each sample within the linear range (13). The x-ray films were analyzed by scanning densitometry and arbitrary densitometric units plotted against the log of the protein concentration determined by methods of Bradford (20). The concentration of surfactant protein for each sample was calculated from the linear portion of the dose-response curve and the data from all groups then normalized to values from the pooled sample of late gestation baboon lung and expressed as a percentage of the level at term. Specificity of these antibodies for use in baboon lung specimens was confirmed in preliminary studies demonstrating extensive reduction in signal using antibodies preabsorbed with respective purified surfactant protein.
Histology and 11ß-HSD-1 and -2 immunocytochemistry
Paraffin-embedded sections of baboon fetal lungs were stained with hematoxylin and eosin and examined by light microscopy. The immunocytochemical detection of 11ß-HSD-1 and -2 proteins in baboon fetal lung was determined essentially as described previously (1, 7). Briefly, peroxidase-blocked sections (4 µm) were microwaved for 15 min in sodium citrate buffer (pH 6.0; Sigma), cooled (30 min), washed in PBS, blocked (30 min) in 5% normal goat serum (Vector Laboratories, Inc., Burlingame, CA) and incubated overnight at 4 C with rabbit primary antibodies to 11ß-HSD-1 or -2 diluted 1:2000 in 5% normal goat serum. After washing, sections were incubated with biotinylated antirabbit IgG (DAKO Corp., Carpenteria, CA) and biotin detected with an avidin peroxidase kit (Vector Laboratories, Inc.). After chromogen development, sections were washed, mounted, and photographed.
RIAs
The levels of estradiol and cortisol in maternal and umbilical venous serum samples were quantified by RIA using an automated chemiluminescent immunoassay system (Immulite, Diagnostic Products, Los Angeles, CA) as described previously for estradiol (17). The antibody for assay of cortisol was highly specific and exhibited minimal (<1%) cross-reactivity with cortisone, progesterone, 11-deoxycortisol, and 17
-hydroxyprogesterone and 8.6% cross-reactivity with corticosterone. Levels of cortisol in maternal (n = 26) and umbilical (n = 26) venous plasma samples assayed undiluted were similar to respective values obtained when samples were diluted 1:2 and 1:3. The inter- and intraassay coefficients of variation were 10.5% and 6.3%, respectively. Maternal (n = 2) and umbilical venous (n = 6) serum samples from baboons in each of the treatment groups were also extracted with ethyl acetate and cortisol purified by Sephadex LH 20 (Pharmacia, Piscataway, NJ) column chromatography as described previously (2). Serum levels (nanomoles per liter) of cortisol in purified samples (624 ± 134) were comparable (correlation coefficient = 0.92) to respective values as determined before purification (681 ± 136) further confirming specificity of the chemiluminescent immunoassay for analysis of cortisol in the baboon. The concentration of cortisol in extracts of fetal lung was determined using a solid-phase 125I RIA kit (Coat-A-Count, Diagnostic Products) the primary antibody of which is the same as that employed in the Immulite procedure. Briefly, 200400 mg fetal lung was homogenized in 5 ml PBS and an aliquot removed for determination of protein using the bicinchoninic procedure (Sigma). Samples were then extracted twice with two volumes of ethyl acetate, solvent evaporated, extracts resuspended in 250 µl RIA buffer, and 25- and 50-µl aliquots analyzed. Cortisol levels in the 50-µl aliquots were uniformly 2-fold (overall mean ± SE, 2.05 ± 0.05) greater than in 25-µl aliquots and samples (n = 4) spiked with excess cortisol; the level of hormone detected (19 ± 2) was not different from that expected (16 ± 1). Fetal lung extracts from two animals in each of the treatment groups were also subjected to Sephadex LH 20 column chromatography. Cortisol levels (nanomoles per gram) in purified samples (0.15 ± 0.04) were comparable (correlation coefficient = 0.95) to respective values determined before purification (0.14 ± 0.03), further confirming specificity of the RIA for analysis of cortisol in fetal baboon lung. The umbilical serum concentrations of corticosteroid-binding globulin (CBG) were determined as described previously (21, 22).
Fetal lung glycogen
Lung glycogen was measured essentially as described by Carroll et al. (23). Briefly, pieces of fetal lung (250900 mg) were sonicated in 5.0 ml distilled H20 (4 C, 45 sec), the homogenate mixed with 20 ml ethyl acetate, and the aqueous fraction mixed with 5.0 ml 10% trichloracetic acid (TCA), centrifuged (2000 x g, 10 min), and the supernatant decanted through 5% TCA-washed filter paper (#1, Whatman). The pellet was resuspended in 5.0 ml 5% TCA, filtered, and glycogen then precipitated overnight with 5.0 ml 95% ethanol and collected by centrifugation (2000 x g, 15 min). The glycogen pellet was dissolved in 2.0 ml distilled H20 and after addition of 10 ml of anthrone (0.5 mg anthrone and 10 mg thiourea/ml 72% H2SO4), samples including glycogen standards were heated at 100 C for 15 min, cooled, and absorbance measured at 620 nm.
 |
Results
|
|---|
Maternal and umbilical venous estradiol levels were suppressed (P < 0.05) by approximately 95% by maternal administration of CGS 20267 (Table 1
). Although treatment with CGS 20267 and estradiol benzoate restored (P < 0.05) maternal estradiol to normal, estrogen levels in umbilical serum were elevated (P < 0.05) to values only 30% of normal. In estrogen-suppressed baboons, serum levels of cortisol in both maternal and umbilical veins were lower (P < 0.05) than respective values in untreated baboons and samples from animals treated with CGS 20267 and estrogen. Levels of CBG in umbilical serum were similar in baboons untreated or treated with CGS 20267 or CGS 20267 and estrogen (Table 1
).
View this table:
[in this window]
[in a new window]
|
Table 1. Effect of CGS 20267 on serum estradiol (nanomoles per liter) and cortisol (nanomoles per liter) in maternal and umbilical veins and serum CBG (nanomoles per liter) in umbilical serum on d 165175 of baboon gestation
|
|
In untreated baboons, wet weight of the fetal lung increased (P < 0.05) approximately 3-fold between d 100 and d 165175 of gestation (Table 2
). A similar increase was observed in fetal body and pituitary weight. These developmental increases in fetal tissue growth were not altered by treatment with CGS 20267 or CGS 20267 and estrogen.
View this table:
[in this window]
[in a new window]
|
Table 2. Baboon fetal body and organ weights at mid (d 100) and late (d 165175) gestation and in late gestation after treatment with CGS 20267
|
|
SP-A protein levels in fetal lungs of untreated baboons were increased (P < 0.05) 16- to 20-fold between d 100 (5.1 ± 1.8) and d 165 (80.2 ± 18.3) and 175 (118.8 ± 25.9) of gestation (Fig 1
). However, the developmental increase in SP-A concentrations was not altered on d 165 in animals in which estrogen was suppressed by CGS 20267 (118.9 ± 19.0) or restored by CGS 20267 and estradiol benzoate (100.4 ± 28.1). SP-B levels in fetal lungs of untreated baboons on d 165 (165.7 ± 23.9) and 175 (146.4 ± 19.9) of gestation were 10-fold greater (P < 0.05) than on d 100 (15.6 ± 11.0; Fig 2
). Moreover, the developmental increase in SP-B also was not altered on d 165 of gestation in fetuses of baboons treated with CGS 20267 (199.6 ± 34.3) or CGS 20267 and estrogen (133.9 ± 25.7).

View larger version (37K):
[in this window]
[in a new window]
|
Figure 1. Effects of aromatase inhibitor CGS 20267 on the developmental expression of SP-A protein in fetal lung of untreated baboons at mid- (d 100; n = 5) and late (d 165; n = 7 and 175; n = 8) gestation and on d 165 of gestation (term = 184 d) in baboons treated with CGS 20267 (12 mg/d sc; n = 12) or CGS 20267 plus estradiol (12 mg/d each sc; n = 7). Lung extracts were examined by immunoblot assay with enhanced chemiluminescence and results expressed as a percentage of values for a pooled sample of late gestation lungs from untreated baboons that was set at 100%. Values with different letter superscripts differ at P < 0.05 (ANOVA; Student Newman Keuls statistic).
|
|

View larger version (36K):
[in this window]
[in a new window]
|
Figure 2. Effects of CGS 20267 on the developmental expression of SP-B protein in fetal lung of untreated baboons at mid- (d 100; n = 5) and late (d 165; n = 7 and 175; n = 8) gestation and on d 165 of gestation in baboons treated with CGS 20267 (n = 12) or CGS 20267 plus estradiol (n = 7). See legend of Fig. 1 for methodological details. Values with different letter superscripts differ at P < 0.05 (ANOVA; Student Newman Keuls statistic).
|
|
The developmental increase in maturation of lung surfactant proteins in untreated baboons was associated with a 10-fold decrease (P < 0.05) in levels of glycogen in fetal lung between d 100 (24.9 ± 1.7 mg/g wet weight; n = 7) and d 165 (2.2 ± 0.4 mg/g; n = 6) of gestation. Although glycogen levels were determined on d 165 in lungs of a small number of baboon fetuses treated with CGS 20267 (n = 2) or CGS 20267 and estrogen (n = 2), levels (0.41.0 mg/g) were in the range of those in lungs of untreated animals.
Although peripheral serum cortisol levels were suppressed by approximately 35% in baboon fetuses of CGS 20267-treated mothers (Fig 3
), cortisol levels in the fetal lung tissue of estrogen-suppressed baboons (0.12 ± 0.02 nmol/g) were similar to respective values in baboons untreated (0.14 ± 0.02) or treated with CGS 20267 and estrogen (0.13 ± 0.03).

View larger version (20K):
[in this window]
[in a new window]
|
Figure 3. Effect of CGS 20267 on cortisol concentrations in peripheral serum (Table 1 ) and extracts of lung of the baboon fetus on d 165175 of gestation (n = 5/group). Values (mean ± SE) with different letter superscripts differ at P < 0.05 (ANOVA; Student Newman Keuls statistic).
|
|
Figure 4
depicts representative histology of the baboon fetal lung on d 100 (A) and d 165 (B) of gestation in untreated baboons and on d 165 in animals treated with CGS 20267 (C) or CGS 20267 and estrogen (D). Although alveolar development was minimal on d 100, by d 165 the baboon fetal lung exhibited an extensive airway branching pattern and numerous alveoli and bronchi/bronchioles. Development of this airway branching pattern as well as alveolar size and septal thickness appeared to be similar in lungs from untreated animals and those treated with CGS 20267 or CGS 20267 and estrogen.

View larger version (152K):
[in this window]
[in a new window]
|
Figure 4. Representative histology of sections of fetal lung obtained on d 100 (A) and 165 (B) of gestation from untreated baboons and on d 165 of gestation from baboons treated with CGS 20267 (C) or CGS 20267 plus estradiol benzoate (D) as described in legend to Table 1 . Paraffin sections (4 µm) were rehydrated in graded alcohols and stained with hematoxylin and eosin. Original magnification, x100.
|
|
Figure 5
depicts the immunocytochemical expression of 11ß-HSD-1 (AD) and 11ß-HSD-2 (EH) proteins in baboon fetal lung on d 100 (A, E) and d 165 (B, F) of gestation in untreated baboons and on d 165 following treatment with CGS 20267 (C, G) or CGS 20267 plus estrogen (D, H). The 11ß-HSD-1 and -2 proteins were not detected by immunocytochemistry in the majority of the fetal lung at midgestation and only occasionally detected in very low levels in epithelial cells of developing bronchi. However, by d 165 of gestation, 11ß-HSD-1 and -2 were abundantly expressed in cytoplasm of epithelial cells of bronchi/bronchioles and only minimally expressed in other cells including alveolar type 1 and 2 epithelial cells. Although neither the site nor extent of 11ß-HSD-1 expression appeared to be modulated by CGS 20267 (C) or CGS 20267 and estrogen (D), the expression of 11ß-HSD-2 in epithelial cells of the bronchi and bronchioles on d 165 of gestation appeared to be decreased by treatment with CGS 20267 (G) and restored to normal by CGS 20267 and estrogen (H).

View larger version (106K):
[in this window]
[in a new window]
|
Figure 5. Representative photomicrographs of the immunocytochemical localization of 11ß-HSD-1 (AD) and 11ß-HSD-2 (EH) in the baboon fetal lung on d 100 (A, E) and d 165 of gestation (BD and FH) in animals that were untreated (A, B, E, F) or treated during the second half of gestation with CGS 20267 (C, G) or CGS 20267 plus estradiol benzoate (D, H) as described in the legend to Table 1 . Sections were incubated with primary antibody to 11ß-HSD-1 or 11ß-HSD-2 and biotinylated antirabbit IgG. Original magnification, x400 (A, E) or x200.
|
|
 |
Discussion
|
|---|
The results of the current study indicate that fetal lung development assessed at term was largely unaltered in baboons in which placental estrogen production and secretion into the fetus were suppressed by maternal administration of CGS 20267 throughout the second half of gestation. Thus, in estrogen-suppressed baboons as in untreated animals, the fetal lung continued to grow and exhibited normal alveolarization on histology. Moreover, the developmental increase in SP-A and SP-B levels and decline in glycogen levels occurred in fetal lungs of untreated and estrogen-deprived baboons. Collectively these observations suggest that fetuses of estrogen-deprived baboons should exhibit normal neonatal respiratory function. In support of this suggestion, in a contemporaneous study of neonatal baboon development, baboon neonates delivered to CGS 20267-treated mothers were able to breathe at delivery without intervention, do not appear to exhibit respiratory problems, and seem to be developing normally (Pepe, G. J., and E. D. Albrecht, in progress). Therefore, it appears that development of the primate fetal lung can occur in utero in baboons in which fetal serum cortisol levels and presumably fetal adrenal cortisol synthesis have been suppressed by the relative absence of estrogen (8) (Albrecht, E. D., and G. J. Pepe, unpublished observations).
The results of the current study also demonstrated that cortisol levels in the fetal lung of estrogen-deprived baboons were similar to those in untreated baboons. The latter occurred despite a marked decline in total levels of fetal serum cortisol and presumably the unbound level of cortisol because concentrations of CBG were also similar in untreated and estrogen-deprived fetuses. Therefore, it is possible that the lung coordinated its production of cortisol by increasing uptake from the circulation and/or regulating local production. Previous studies have shown that conversion of 11-ketosteroids (e.g. cortisone) to 11-oxosteroids (e.g. cortisol) is increased in the rodent fetal lung in late gestation (24, 25) and human fetal lung in culture (26, 27). Moreover, surfactant phosphatidylcholine synthesis and 11ß-HSD-1 activity are highly correlated late in gestation in the fetal rat lung (28), and the latter may also occur in the baboon lung. Thus, expression of the 11ß-HSD-1 enzyme catalyzing conversion of biologically inactive cortisone to biologically active cortisol (6) in bronchiole epithelial cells and consequently potential for production of cortisol from cortisone were maintained at normal levels in estrogen-deprived baboons. The current study, however, also showed that bronchiolar epithelial cells of the baboon as in human fetal lung (29, 30) in late gestation expressed the 11ß-HSD-2 enzyme, which catalyzes the oxidation of cortisol to cortisone. Thus, the primate fetal lung also has the capacity to convert cortisol to inactive cortisone as originally shown by Murphy (31) in human fetal lung.
Interestingly, it appeared that 11ß-HSD-2 expression was decreased in fetal lungs of estrogen-suppressed baboons, although the latter must be confirmed using more quantitative approaches. However, a reduction in 11ß-HSD-2 expression is consistent with our previous studies using isotope dilution that the peripheral transfer constant for conversion of cortisol to cortisone by the baboon fetus was up-regulated by estradiol (32) and suppressed at term in baboon neonates delivered to mothers treated with an antiestrogen (33). Interestingly, estrogen had no effect on the overall conversion of cortisone to cortisol. Because the peripheral transfer constant represents the sum of all tissue beds metabolizing glucocorticoid, it remains to be determined whether cortisol-cortisone interconversion is regulated by estrogen in fetal baboon lung. Nevertheless, based on our immunocytochemical observations, the maintenance of high 11ß-HSD-1 and decreased 11ß-HSD-2 levels in fetal lung of estrogen-suppressed baboons could provide a mechanism to increase lung cortisol levels in the face of decreased availability of peripheral cortisol.
The results of the current study also suggest that both 11ß-HSD-1 and -2 were expressed in the same cells of the baboon fetal lung. These enzymes are also coexpressed in the baboon and human placental syncytiotrophoblast (1). In the placenta, estrogen has been shown to up-regulate both 11ß-HSD-1 and -2 expression (1, 2, 3), and 11ß-HSD-1 and -2 expression in the fetal lung was markedly increased between mid- and late gestation. However, in the current study, as in our previous experiments using isotope dilution, estrogen appeared to modulate only the oxidation of cortisol to cortisone, i.e. the 11ß-HSD-2 enzyme. Thus, 11ß-HSD-1 expression in fetal lung may be regulated by factors other than or in addition to estrogen. For example, cortisol has also been shown to modulate 11ß-HSD-1 expression in fetal and adult sheep liver (34). However, the role of cortisol on baboon fetal lung 11ß-HSD-1 expression remains to be ascertained.
The increase in SP-A and SP-B expression in fetal lung of untreated baboons of the current study confirms the elegant work of Coalson et al. (14). These investigators clearly showed using in situ hybridization that SP-A and SP-B were expressed in alveolar epithelial type II cells as well as bronchial and bronchiolar epithelial cells and that SP-C was expressed in loci of epithelial cells in respiratory bronchioles. Gao et al. (15) have also shown that SP-A mRNA levels in fetal baboon lung were barely detectable on d 92 of gestation increased 4-fold between d 120 and d 140 and an additional 7-fold by d 160. A similar pattern and developmental expression of SP-A and SP-B apparently occurs in the human fetal lung (35, 36). Finally, although surfactant synthesis is normal in SP-A-deficient mice (37, 38), SP-A null mice exhibit increased susceptibility to infection (39). Therefore, it appears that SP-A may primarily exhibit an important nonsurfactant associated role (e.g. host defense) in lung function (40).
The regulation of SP-A and SP-B gene expression appears to be extremely complex and multifactorial in nature (15, 41, 42). In studies of human fetal lung in culture, Boggaram et al. (41, 42, 43) have shown that cAMP and glucocorticoids increase transcriptional activity of the SP-A gene but that paradoxically glucocorticoids also cause a dose-dependent inhibition of SP-A mRNA stability. Similar to observations in midgestation human fetal lungs, cAMP-enhanced SP-A gene expression in baboon fetal lungs obtained on d 90 and d 140 of gestation and cAMP-induced SP-A expression was inhibited by dexamethasone in a dose-dependent manner (16). However, these effects were not manifest in lungs obtained from baboons on d 165174 of gestation, indicating that there is a decrease in the responsiveness of the baboon fetal lung to the stimulatory effects of cAMP and the inhibitory effects of glucocorticoids. Further study is required to ascertain the factors acting/interacting to regulate basal expression of the surfactant proteins as well as lung growth and differentiation. However, the similarity in gene expression and developmental regulation in the baboon and human support the use of this nonhuman primate model to perform such studies.
 |
Acknowledgments
|
|---|
The generous gift of CGS 20267 was graciously provided by Norvartis Pharma AG (Basel Switzerland). We sincerely appreciate the secretarial assistance of Sandra Huband with the manuscript; Nicholas Zachos with the preparation of the photomicrographs and lung cortisol assays; Geoffrey Hammond, Ph.D. (London Regional Cancer Centre, London, Ontario, Canada), for CBG analyses; Marcia G. Burch with the immunocytochemistry; and Carol Stapanowich, Ph.D., with the histology. The enthusiasm and early work of Steven G. Bassett, Ph.D., on baboon lung development is sincerely appreciated.
 |
Footnotes
|
|---|
This work was supported by NIH Research Grant R01 HD-13294 and HL-19737.
Abbreviations: 11ß-HSD, 11ß-Hydroxysteroid dehydrogenase; CBG, corticosteroid-binding globulin; SP, surfactant protein; TCA, trichloroacetic acid.
Received February 12, 2002.
Accepted October 14, 2002.
 |
References
|
|---|
- Pepe GJ, Burch MG, Albrecht ED 1999 Expression of the 11ß-hydroxysteroid dehydrogenase types 1 and 2 proteins in human and baboon placental syncytiotrophoblast. Placenta 20:575582[CrossRef][Medline]
- Pepe GJ, Burch MG, Albrecht ED 2001 Localization and developmental regulation of 11ß-hydroxysteroid dehydrogenase-1 and -2 in the baboon syncytiotrophoblast. Endocrinology 142:6880[Abstract/Free Full Text]
- Pepe GJ, Waddell BJ, Stahl SJ, Albrecht ED 1988 The regulation of transplacental cortisol-cortisone metabolism by estrogen in pregnant baboons. Endocrinology 122:7883[Abstract]
- Pepe GJ, Davies WA, Albrecht ED 1994 Activation of the baboon fetal pituitary-adrenocortical axis at midgestation by estrogen: enhancement of fetal pituitary proopiomelanocortin messenger ribonucleic acid expression. Endocrinology 135:25812587[Abstract]
- Pepe GJ, Waddell BJ, Albrecht ED 1990 Activation of the baboon fetal hypothalamic-pituitary-adrenocortical axis at midgestation by estrogen-induced changes in placental corticosteroid metabolism. Endocrinology 127:31173123[Abstract]
- Pepe GJ, Albrecht ED 1995 Actions of placental and fetal adrenal steroid hormones in primate pregnancy. Endocr Rev 16:608648[Abstract]
- Pepe GJ, Burch MG, Albrecht ED 2001 Estrogen regulates 11ß-hydroxysteroid dehydrogenase -1 and -2 localization in placental syncytiotrophoblast in the second half of primate pregnancy. Endocrinology 142:44964503[Abstract/Free Full Text]
- Pepe GJ, Albrecht ED 1991 Activation of the baboon fetal pituitary-adrenocortical axis at midgestation by estrogen: adrenal
5-3ß-hydroxysteroid dehydrogenase and 17
-hydroxylase-1720-lyase activity. Endocrinology 128:23952401[Abstract]
- Liggins GC 1969 Premature delivery of foetal lambs infused with glucocorticoids. J Endocrinol 45:515523
- Boggaram V, Mendelson CR 1988 Transcriptional regulation of the gene encoding the major surfactant protein (SP-A) in rabbit fetal lung. J Biol Chem 263:1906019065[Abstract/Free Full Text]
- Kotas RV, Avery ME 1971 Accelerated appearance of pulmonary surfactant in the fetal rabbit. J Appl Physiol 30:358361[Free Full Text]
- Iannuzzi DM, Ertsey R, Ballard PL 1993 Biphasic glucocorticoid regulation of pulmonary SP-A: characterization of inhibitory process. Am J Physiol 264:L236L244
- Ballard PL, Ning Y, Polk D, Ikegami M, Jobe AH 1997 Glucocorticoid regulation of surfactant components in immature lambs. Am J Physiol 273:L1048L1057
- Coalson JJ, Winter V, Yang F 1998 Site specificity and surfactant protein expression in airways of baboons during gestation. Anat Rec 250:300315[CrossRef][Medline]
- Gao E, Wang Y, McCormick SM, Li J, Seidner SR, Mendelson CR 1996 Characterization of two baboon surfactant protein A genes. Am J Physiol 271:L617L630
- Seidner SR, Smith ME, Mendelson CR 1996 Developmental and hormonal regulation of SP-A gene expression in baboon fetal lung. Am J Physiol 271:L609L616
- Albrecht ED, Aberdeen GW, Pepe GJ 2000 The role of estrogen in the maintenance of primate pregnancy. Am J Obstet Gynecol 182:432438[CrossRef][Medline]
- Beers MF, Bates SR, Fisher AB 1992 Differential extraction for the rapid purification of bovine surfactant protein B. Am J Physiol 262:L773L778
- Wali A, Beers MF, Dodia C, Feinstein SI, Fisher AB 1993 ATP and cAMP stimulate the synthesis of surfactant protein SP-A in rat lung. Am J Physiol 264:L431L437
- Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248254[CrossRef][Medline]
- Pepe GJ, Hodgert Jury H, Hammond GL, Albrecht ED 1996 Developmental regulation of corticosteroid-binding globulin biosynthesis in the baboon fetus. Endocrinology 137:33233328[Abstract]
- Hammond GL, Lahteenmaki PLA 1983 A versatile method for the determination of serum cortisol binding globulin and sex hormone binding globulin binding capacities. Clin Chim Acta 132:101110[CrossRef][Medline]
- Carroll NV, Longley RW, Roe JH 1956 The determination of glycogen in liver and muscle by use of anthrone reagent. J Biol Chem 220:583593[Free Full Text]
- Smith BT, Giroud CJP 1974 Uptake and metabolism of cortisone and cortisol by the fetal rabbit lung. Steroids 23:845853[CrossRef][Medline]
- Giannopoulos G 1975 Early events in the action of glucocorticoids in developing tissues. J Steroid Biochem 6:623631[CrossRef][Medline]
- Abramovitz M, Carriero R, Murphy BEP 1984 Investigation of factors influencing 11ß-hydroxysteroid dehydrogenase (EC 1.1.1.146) activity in midgestational human fetal lung monolayer and explant cultures. J Steroid Biochem 21:677683[CrossRef][Medline]
- Smith BT, Torday JS, Giroud CJP 1974 The growth promoting effect of cortisol on human fetal lung cells. Steroids 22:515524
- Hundertmark S, Buhler H, Ragosch V, Dinkelborg L, Arabin B, Weitzel HK 1995 Correlation of surfactant phosphatidylcholine synthesis and 11ß-hydroxysteroid dehydrogenase in the fetal lung. Endocrinology 136:25732578[Abstract]
- Condon J, Gosden C, Gardener D, Nickson P, Hewison M, Howie AJ, Stewart PM 1998 Expression of type 2 11ß-hydroxysteroid dehydrogenase and corticosteroid hormone receptors in early human fetal life. J Clin Endocrinol Metab 83:44904497[Abstract/Free Full Text]
- Suzuki T, Sasano H, Suzuki S, Hirasawa G, Takeyama J, Muramatsu Y, Date F, Nagura H, Krozowski Z 1998 11ß-hydroxysteroid dehydrogenase type 2 in human lung: possible regulator of mineralocorticoid action. J Clin Endocrinol Metab 83:40224025[Abstract/Free Full Text]
- Murphy BEP 1981 Ontogeny of cortisol-cortisone interconversion in human tissues: a role for cortisone in human fetal development. J Steroid Biochem 14:811817[CrossRef][Medline]
- Waddell BJ, Albrecht ED, Pepe GJ 1988 Effect of estrogen on the metabolism of cortisol and cortisone in the baboon fetus at midgestation. Biol Reprod 38:10061011[Abstract]
- Albrecht ED, Johnson DK, Pepe GJ 1981 Effect of maternal administration of the antiestrogen ethamoxytriphetol throughout the last third of baboon gestation upon neonatal corticoid production. Steroids 37:4550[CrossRef][Medline]
- Yang K, Berdusco ETM, Challis JRG 1994 Opposite effects of glucocorticoid on hepatic 11ß-hydroxysteroid dehydrogenase mRNA and activity in fetal and adult sheep. J Endocrinol 143:121126[Abstract]
- Khoor A, Gray ME, Hull WM, Whitsett JA, Stahlman MT 1993 Developmental expression of SP-A and SP-A mRNA in the proximal and distal respiratory epithelium in the human fetus and newborn. J Histochem Cytochem 41:13111319[Abstract]
- Khoor A, Stahlman MT, Gray ME, Whitsett JA 1994 Temporal-spatial distribution of SP-B and SP-C proteins and mRNAs in developing respiratory epithelium of human lung. J Histochem Cytochem 42:11871199[Abstract]
- Korfhagen TR, Bruno MD, Ross GF, Huelsman KM, Ikegami M, Jobe AH, Wert SE, Stripp BR, Morris RE, Glasser SW, Bachurski CJ, Iwamoto HS, Whitsett JA 1996 Altered surfactant function and structure in SP-A gene targeted mice. Proc Natl Acad Sci USA 93:95949599[Abstract/Free Full Text]
- Ikegami M, Korfhagen TR, Bruno MD, Whitsett JA, Jobe AH 1997 Surfactant metabolism in surfactant protein A-deficient mice. Am J Physiol 272:L479L485
- LeVine AM, Kurak KE, Wright JR, Watford WT, Bruno MD, Ross GF, Whitsett JA, Korfhagen TR 1999 Surfactant protein-A binds group B streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice. Am J Respir Cell Mol Biol 20:279286[Abstract/Free Full Text]
- Korfhagen TR, LeVine AM, Whitsett JA 1998 Surfactant protein A (SP-A) gene targeted mice. Biochim Biophys Acta 1408:296302[Medline]
- Boggaram V, Qing K, Mendelson CR 1988 Rabbit pulmonary surfactant apoprotein: elucidation of primary sequence and hormonal and developmental regulation. J Biol Chem 263:29392947[Abstract/Free Full Text]
- Boggaram V, Smith ME, Mendelson CR 1991 Posttranscriptional regulation of surfactant protein A (SP-A) mRNA in human fetal lung in vitro by glucocorticoids. Mol Endocrinol 5:414423[Abstract]
- Boggaram V, Smith ME, Mendelson CR 1988 Regulation of expression of the gene encoding the major surfactant protein (SP-A) in human fetal lung in vitro. J Biol Chem 264:1142111427
This article has been cited by other articles:

|
 |

|
 |
 
L. A. Cox, M. J. Nijland, J. S. Gilbert, N. E. Schlabritz-Loutsevitch, G. B. Hubbard, T. J. McDonald, R. E. Shade, and P. W. Nathanielsz
Effect of 30 per cent maternal nutrient restriction from 0.16 to 0.5 gestation on fetal baboon kidney gene expression
J. Physiol.,
April 1, 2006;
572(1):
67 - 85.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Henson and V. D. Castracane
Leptin in Pregnancy: An Update
Biol Reprod,
February 1, 2006;
74(2):
218 - 229.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. D. Albrecht, G. W. Aberdeen, and G. J. Pepe
Estrogen Elicits Cortical Zone-Specific Effects on Development of the Primate Fetal Adrenal Gland
Endocrinology,
April 1, 2005;
146(4):
1737 - 1744.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M C Henson, K F Swan, D E Edwards, G W Hoyle, J Purcell, and V D Castracane
Leptin receptor expression in fetal lung increases in late gestation in the baboon: a model for human pregnancy
Reproduction,
January 1, 2004;
127(1):
87 - 94.
[Abstract]
[Full Text]
[PDF]
|
 |
|